These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10645478)

  • 1. [Mechanism of action of aspartyl proteinases. VI. Nonvalent enzyme-inhibitory and enzyme-substrate complexes of the aspartyl proteinase rhizopus pepsin].
    Kashparov IV; Popov ME; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Oct; 25(10):747-62. PubMed ID: 10645478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of aspartyl proteinase action. VII. Noncovalent complexes of HIV-1 aspartyl proteinase with substrate and substrate-like inhibitors].
    Popov ME; Kashparov IV; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Dec; 25(12):911-22. PubMed ID: 10734551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of aspartic proteases. IV.Conformational characteristics of a substrate and an inhibitor of rhizopuspepsin ].
    Kashparov IV; Popov ME; Popov EM
    Bioorg Khim; 1999 Jun; 25(6):423-34. PubMed ID: 10505230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of aspartic proteinases. V. Conformational characteristics of fragments of substrate-binding sites in rhizopuspepsin and HIV-1 proteinase].
    Kashparov IV; Popov ME; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Aug; 25(8):597-602. PubMed ID: 10578465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
    Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
    J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
    Bailey D; Cooper JB
    Protein Sci; 1994 Nov; 3(11):2129-43. PubMed ID: 7703859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action of aspartic proteases. III. Conformational characteristics of HIV-1 protease inhibitor JG-365].
    Popov ME; Kashparov IV; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Jun; 25(6):418-22. PubMed ID: 10505229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
    Veerapandian B; Cooper JB; Sali A; Blundell TL; Rosati RL; Dominy BW; Damon DB; Hoover DJ
    Protein Sci; 1992 Mar; 1(3):322-8. PubMed ID: 1304340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrocyclic statine-based inhibitors of BACE-1.
    Barazza A; Götz M; Cadamuro SA; Goettig P; Willem M; Steuber H; Kohler T; Jestel A; Reinemer P; Renner C; Bode W; Moroder L
    Chembiochem; 2007 Nov; 8(17):2078-91. PubMed ID: 17963207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theoretical study of torsional flexibility in the active site of aspartic proteinases: implications for catalysis.
    Beveridge A
    Proteins; 1996 Mar; 24(3):322-34. PubMed ID: 8778779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
    Suguna K; Padlan EA; Bott R; Boger J; Parris KD; Davies DR
    Proteins; 1992 Jul; 13(3):195-205. PubMed ID: 1603809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
    Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
    J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.
    Laco GS; Schalk-Hihi C; Lubkowski J; Morris G; Zdanov A; Olson A; Elder JH; Wlodawer A; Gustchina A
    Biochemistry; 1997 Sep; 36(35):10696-708. PubMed ID: 9271500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.
    Wilderspin AF; Sugrue RJ
    J Mol Biol; 1994 May; 239(1):97-103. PubMed ID: 8196050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational flexibility of beta-secretase: molecular dynamics simulation and essential dynamics analysis.
    Xiong B; Huang XQ; Shen LL; Shen JH; Luo XM; Shen X; Jiang HL; Chen KX
    Acta Pharmacol Sin; 2004 Jun; 25(6):705-13. PubMed ID: 15169620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action.
    Suguna K; Padlan EA; Smith CW; Carlson WD; Davies DR
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7009-13. PubMed ID: 3313384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined quantum/classical molecular dynamics study of the catalytic mechanism of HIV protease.
    Liu H; Müller-Plathe F; van Gunsteren WF
    J Mol Biol; 1996 Aug; 261(3):454-69. PubMed ID: 8780786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a new Rhizopuspepsin from Rhizopus oryzae NBRC 4749.
    Chen CC; Cho YC; Lai CC; Hsu WH
    J Agric Food Chem; 2009 Aug; 57(15):6742-7. PubMed ID: 19722576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial aspartic proteinase system.
    Jiang L; Liu Z; Liang Z; Gao Y
    Bioorg Med Chem; 2005 Jun; 13(11):3673-80. PubMed ID: 15862996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.